[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fryAhcXRFv0V815BL_uxDAJxecpqxSt3QfYpfr5xk3C0":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":45,"rows":52},"Umeå University",[4],263,false,63,10,2597409,3,244,[14,17,20,23,25,27,30,32],{"name":15,"count":16},"Healthy",8,{"name":18,"count":19},"Stroke",7,{"name":21,"count":22},"Obesity",6,{"name":24,"count":22},"Depression",{"name":26,"count":22},"Postoperative Complications",{"name":28,"count":29},"Social Phobia",4,{"name":31,"count":29},"Hypertension",{"name":33,"count":29},"Breast Cancer",[35,40],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT05164081","Dual vs. Single-Antibiotic Impregnated Cement in Hemiarthroplasty for Femoral Neck Fracture","2026-01-31","antibiotic loaded bone cement (gentamicin+clindamycin) COPAL G+C (Heraeus).",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT04079049","BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases","2029-12-31","Control",[46,47,48,49,50,51],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[53,80,98,120,150,181,199,227,245,263,281,307,325,353,371,397,415,441,459,486,504,530,548,573,599,617,643,678,696,714,732,750,768,786,804,827,853,880],{"intervention":39,"totalTrials":54,"cells":55},1,{"EARLY_PHASE1":56,"PHASE1":59,"PHASE2":61,"PHASE3":63,"PHASE4":76,"NA":78},{"trials":57,"activeCount":58},[],0,{"trials":60,"activeCount":58},[],{"trials":62,"activeCount":58},[],{"trials":64,"activeCount":54,"soonestReadout":38},[65],{"nctId":36,"briefTitle":37,"status":66,"phases":67,"primaryCompletion":38,"completion":68,"start":69,"enrollment":70,"conditions":71,"interventions":74},"ACTIVE_NOT_RECRUITING",[49],"2027-01-31","2022-01-01",7000,[72,73],"Femoral Neck Fractures","Prosthetic Infection",[39,75],"antibiotic loaded bone cement (gentamicin) Paladins R+G (Heraeus) or Refobacin (Biomet).",{"trials":77,"activeCount":58},[],{"trials":79,"activeCount":58},[],{"intervention":75,"totalTrials":54,"cells":81},{"EARLY_PHASE1":82,"PHASE1":84,"PHASE2":86,"PHASE3":88,"PHASE4":94,"NA":96},{"trials":83,"activeCount":58},[],{"trials":85,"activeCount":58},[],{"trials":87,"activeCount":58},[],{"trials":89,"activeCount":54,"soonestReadout":38},[90],{"nctId":36,"briefTitle":37,"status":66,"phases":91,"primaryCompletion":38,"completion":68,"start":69,"enrollment":70,"conditions":92,"interventions":93},[49],[72,73],[39,75],{"trials":95,"activeCount":58},[],{"trials":97,"activeCount":58},[],{"intervention":44,"totalTrials":54,"cells":99},{"EARLY_PHASE1":100,"PHASE1":102,"PHASE2":104,"PHASE3":106,"PHASE4":116,"NA":118},{"trials":101,"activeCount":58},[],{"trials":103,"activeCount":58},[],{"trials":105,"activeCount":58},[],{"trials":107,"activeCount":54,"soonestReadout":43},[108],{"nctId":41,"briefTitle":42,"status":109,"phases":110,"primaryCompletion":43,"completion":43,"start":111,"enrollment":112,"conditions":113,"interventions":115},"RECRUITING",[49],"2020-01-01",200,[33,114],"Liver Metastases",[44],{"trials":117,"activeCount":58},[],{"trials":119,"activeCount":58},[],{"intervention":121,"totalTrials":54,"cells":122},"Iron",{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":129,"PHASE4":131,"NA":148},{"trials":124,"activeCount":58},[],{"trials":126,"activeCount":58},[],{"trials":128,"activeCount":58},[],{"trials":130,"activeCount":58},[],{"trials":132,"activeCount":58},[133],{"nctId":134,"briefTitle":135,"status":136,"phases":137,"primaryCompletion":138,"completion":139,"start":140,"enrollment":141,"conditions":142,"interventions":147},"NCT00558454","Iron Supplementation of Marginally Low Birth Weight Infants","COMPLETED",[50],"2008-06","2014-11","2004-03",380,[143,144,145,146],"Anemia","Iron-Deficiency","Child Behavior Disorders","Cognitive Manifestations",[121],{"trials":149,"activeCount":58},[],{"intervention":151,"totalTrials":54,"cells":152},"Betamethason Sodium Phosphate",{"EARLY_PHASE1":153,"PHASE1":155,"PHASE2":157,"PHASE3":159,"PHASE4":161,"NA":179},{"trials":154,"activeCount":58},[],{"trials":156,"activeCount":58},[],{"trials":158,"activeCount":58},[],{"trials":160,"activeCount":58},[],{"trials":162,"activeCount":58},[163],{"nctId":164,"briefTitle":165,"status":166,"phases":167,"primaryCompletion":168,"completion":169,"start":170,"enrollment":171,"conditions":172,"interventions":177},"NCT03783182","Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy","UNKNOWN",[50],"2025-06-20","2025-12-15","2019-09-10",100,[173,174,175,176],"Tonsillectomy","Pain","PONV","Bleeding",[151,178],"10% glucose solution",{"trials":180,"activeCount":58},[],{"intervention":178,"totalTrials":54,"cells":182},{"EARLY_PHASE1":183,"PHASE1":185,"PHASE2":187,"PHASE3":189,"PHASE4":191,"NA":197},{"trials":184,"activeCount":58},[],{"trials":186,"activeCount":58},[],{"trials":188,"activeCount":58},[],{"trials":190,"activeCount":58},[],{"trials":192,"activeCount":58},[193],{"nctId":164,"briefTitle":165,"status":166,"phases":194,"primaryCompletion":168,"completion":169,"start":170,"enrollment":171,"conditions":195,"interventions":196},[50],[173,174,175,176],[151,178],{"trials":198,"activeCount":58},[],{"intervention":200,"totalTrials":54,"cells":201},"Cholecalciferol high dose at Vitamin D deficiency",{"EARLY_PHASE1":202,"PHASE1":204,"PHASE2":206,"PHASE3":208,"PHASE4":210,"NA":225},{"trials":203,"activeCount":58},[],{"trials":205,"activeCount":58},[],{"trials":207,"activeCount":58},[],{"trials":209,"activeCount":58},[],{"trials":211,"activeCount":58},[212],{"nctId":213,"briefTitle":214,"status":136,"phases":215,"primaryCompletion":216,"completion":216,"start":217,"enrollment":218,"conditions":219,"interventions":221},"NCT01419119","Vitamin Deficiency in Immigrants, a Treatment Study",[50],"2012-10","2011-09",160,[220],"Vitamin D Deficiency",[200,222,223,224],"Cholecalciferol median dose at Vitamin D insufficiency","Cholecalciferol low dose at Vitamin D deficiency","Cholecalciferol median dose at sufficient Vitamin D level",{"trials":226,"activeCount":58},[],{"intervention":222,"totalTrials":54,"cells":228},{"EARLY_PHASE1":229,"PHASE1":231,"PHASE2":233,"PHASE3":235,"PHASE4":237,"NA":243},{"trials":230,"activeCount":58},[],{"trials":232,"activeCount":58},[],{"trials":234,"activeCount":58},[],{"trials":236,"activeCount":58},[],{"trials":238,"activeCount":58},[239],{"nctId":213,"briefTitle":214,"status":136,"phases":240,"primaryCompletion":216,"completion":216,"start":217,"enrollment":218,"conditions":241,"interventions":242},[50],[220],[200,222,223,224],{"trials":244,"activeCount":58},[],{"intervention":223,"totalTrials":54,"cells":246},{"EARLY_PHASE1":247,"PHASE1":249,"PHASE2":251,"PHASE3":253,"PHASE4":255,"NA":261},{"trials":248,"activeCount":58},[],{"trials":250,"activeCount":58},[],{"trials":252,"activeCount":58},[],{"trials":254,"activeCount":58},[],{"trials":256,"activeCount":58},[257],{"nctId":213,"briefTitle":214,"status":136,"phases":258,"primaryCompletion":216,"completion":216,"start":217,"enrollment":218,"conditions":259,"interventions":260},[50],[220],[200,222,223,224],{"trials":262,"activeCount":58},[],{"intervention":224,"totalTrials":54,"cells":264},{"EARLY_PHASE1":265,"PHASE1":267,"PHASE2":269,"PHASE3":271,"PHASE4":273,"NA":279},{"trials":266,"activeCount":58},[],{"trials":268,"activeCount":58},[],{"trials":270,"activeCount":58},[],{"trials":272,"activeCount":58},[],{"trials":274,"activeCount":58},[275],{"nctId":213,"briefTitle":214,"status":136,"phases":276,"primaryCompletion":216,"completion":216,"start":217,"enrollment":218,"conditions":277,"interventions":278},[50],[220],[200,222,223,224],{"trials":280,"activeCount":58},[],{"intervention":282,"totalTrials":54,"cells":283},"PEG",{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":290,"PHASE4":303,"NA":305},{"trials":285,"activeCount":58},[],{"trials":287,"activeCount":58},[],{"trials":289,"activeCount":58},[],{"trials":291,"activeCount":58},[292],{"nctId":293,"briefTitle":294,"status":136,"phases":295,"primaryCompletion":296,"completion":296,"start":297,"enrollment":298,"conditions":299,"interventions":301},"NCT00390598","PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy",[48,49],"2006-12","2005-09",490,[300],"Colonoscopy",[282,302],"senna glycoside 36 mg and PEG",{"trials":304,"activeCount":58},[],{"trials":306,"activeCount":58},[],{"intervention":302,"totalTrials":54,"cells":308},{"EARLY_PHASE1":309,"PHASE1":311,"PHASE2":313,"PHASE3":315,"PHASE4":321,"NA":323},{"trials":310,"activeCount":58},[],{"trials":312,"activeCount":58},[],{"trials":314,"activeCount":58},[],{"trials":316,"activeCount":58},[317],{"nctId":293,"briefTitle":294,"status":136,"phases":318,"primaryCompletion":296,"completion":296,"start":297,"enrollment":298,"conditions":319,"interventions":320},[48,49],[300],[282,302],{"trials":322,"activeCount":58},[],{"trials":324,"activeCount":58},[],{"intervention":326,"totalTrials":54,"cells":327},"klonidin",{"EARLY_PHASE1":328,"PHASE1":330,"PHASE2":332,"PHASE3":334,"PHASE4":349,"NA":351},{"trials":329,"activeCount":58},[],{"trials":331,"activeCount":58},[],{"trials":333,"activeCount":58},[],{"trials":335,"activeCount":58},[336],{"nctId":337,"briefTitle":338,"status":136,"phases":339,"primaryCompletion":340,"completion":340,"start":341,"enrollment":342,"conditions":343,"interventions":347},"NCT02030717","Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma",[48,49],"2015-05","2012-02",120,[344,345,346],"Pre- and Postoperative Analgesia","Spinal Anesthesia","Renal Cell Carcinoma",[326,348],"epidural anesthesia",{"trials":350,"activeCount":58},[],{"trials":352,"activeCount":58},[],{"intervention":348,"totalTrials":54,"cells":354},{"EARLY_PHASE1":355,"PHASE1":357,"PHASE2":359,"PHASE3":361,"PHASE4":367,"NA":369},{"trials":356,"activeCount":58},[],{"trials":358,"activeCount":58},[],{"trials":360,"activeCount":58},[],{"trials":362,"activeCount":58},[363],{"nctId":337,"briefTitle":338,"status":136,"phases":364,"primaryCompletion":340,"completion":340,"start":341,"enrollment":342,"conditions":365,"interventions":366},[48,49],[344,345,346],[326,348],{"trials":368,"activeCount":58},[],{"trials":370,"activeCount":58},[],{"intervention":372,"totalTrials":54,"cells":373},"SonoVue",{"EARLY_PHASE1":374,"PHASE1":376,"PHASE2":378,"PHASE3":380,"PHASE4":393,"NA":395},{"trials":375,"activeCount":58},[],{"trials":377,"activeCount":58},[],{"trials":379,"activeCount":58},[],{"trials":381,"activeCount":58},[382],{"nctId":383,"briefTitle":384,"status":385,"phases":386,"primaryCompletion":387,"completion":387,"start":388,"enrollment":54,"conditions":389,"interventions":391},"NCT03290053","Contrast Enhanced Sonothrombolysis and Sonolysis in Stroke - a Swedish Study (CE-5S)","TERMINATED",[49],"2018-04-18","2017-11-28",[390],"Ischemic Stroke",[372,392],"Sodium chloride",{"trials":394,"activeCount":58},[],{"trials":396,"activeCount":58},[],{"intervention":392,"totalTrials":54,"cells":398},{"EARLY_PHASE1":399,"PHASE1":401,"PHASE2":403,"PHASE3":405,"PHASE4":411,"NA":413},{"trials":400,"activeCount":58},[],{"trials":402,"activeCount":58},[],{"trials":404,"activeCount":58},[],{"trials":406,"activeCount":58},[407],{"nctId":383,"briefTitle":384,"status":385,"phases":408,"primaryCompletion":387,"completion":387,"start":388,"enrollment":54,"conditions":409,"interventions":410},[49],[390],[372,392],{"trials":412,"activeCount":58},[],{"trials":414,"activeCount":58},[],{"intervention":416,"totalTrials":54,"cells":417},"Doxycycline",{"EARLY_PHASE1":418,"PHASE1":420,"PHASE2":422,"PHASE3":435,"PHASE4":437,"NA":439},{"trials":419,"activeCount":58},[],{"trials":421,"activeCount":58},[],{"trials":423,"activeCount":58},[424],{"nctId":425,"briefTitle":426,"status":136,"phases":427,"primaryCompletion":428,"completion":428,"start":341,"enrollment":429,"conditions":430,"interventions":433},"NCT02016365","Safety and Efficacy Study of Doxycycline\u002FUrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis",[48],"2014-12",55,[431,432],"Transthyretin Amyloidosis","Cardiomyopathy",[416,434],"Ursodeoxycholic acid",{"trials":436,"activeCount":58},[],{"trials":438,"activeCount":58},[],{"trials":440,"activeCount":58},[],{"intervention":434,"totalTrials":54,"cells":442},{"EARLY_PHASE1":443,"PHASE1":445,"PHASE2":447,"PHASE3":453,"PHASE4":455,"NA":457},{"trials":444,"activeCount":58},[],{"trials":446,"activeCount":58},[],{"trials":448,"activeCount":58},[449],{"nctId":425,"briefTitle":426,"status":136,"phases":450,"primaryCompletion":428,"completion":428,"start":341,"enrollment":429,"conditions":451,"interventions":452},[48],[431,432],[416,434],{"trials":454,"activeCount":58},[],{"trials":456,"activeCount":58},[],{"trials":458,"activeCount":58},[],{"intervention":460,"totalTrials":54,"cells":461},"Trimethoprim\u002FSulfamethoxazole",{"EARLY_PHASE1":462,"PHASE1":464,"PHASE2":466,"PHASE3":480,"PHASE4":482,"NA":484},{"trials":463,"activeCount":58},[],{"trials":465,"activeCount":58},[],{"trials":467,"activeCount":58},[468],{"nctId":469,"briefTitle":470,"status":166,"phases":471,"primaryCompletion":472,"completion":473,"start":474,"enrollment":475,"conditions":476,"interventions":478},"NCT02734732","Antibiotic Prophylaxis for Transrectal Prostate Biopsy-Ciprofloxacin vs. Trimethoprim\u002FSulfamethoxazole",[48],"2020-04","2020-05","2015-04",2800,[477],"Prostate Infection",[460,479],"Ciprofloxacin",{"trials":481,"activeCount":58},[],{"trials":483,"activeCount":58},[],{"trials":485,"activeCount":58},[],{"intervention":479,"totalTrials":54,"cells":487},{"EARLY_PHASE1":488,"PHASE1":490,"PHASE2":492,"PHASE3":498,"PHASE4":500,"NA":502},{"trials":489,"activeCount":58},[],{"trials":491,"activeCount":58},[],{"trials":493,"activeCount":58},[494],{"nctId":469,"briefTitle":470,"status":166,"phases":495,"primaryCompletion":472,"completion":473,"start":474,"enrollment":475,"conditions":496,"interventions":497},[48],[477],[460,479],{"trials":499,"activeCount":58},[],{"trials":501,"activeCount":58},[],{"trials":503,"activeCount":58},[],{"intervention":505,"totalTrials":54,"cells":506},"Hydrochlorothiazide",{"EARLY_PHASE1":507,"PHASE1":509,"PHASE2":511,"PHASE3":524,"PHASE4":526,"NA":528},{"trials":508,"activeCount":58},[],{"trials":510,"activeCount":58},[],{"trials":512,"activeCount":58},[513],{"nctId":514,"briefTitle":515,"status":136,"phases":516,"primaryCompletion":517,"completion":518,"start":519,"enrollment":520,"conditions":521,"interventions":522},"NCT00282178","Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo",[48],"2006-03","2006-04","2005-04",26,[31,21],[505,523],"Candesartan",{"trials":525,"activeCount":58},[],{"trials":527,"activeCount":58},[],{"trials":529,"activeCount":58},[],{"intervention":523,"totalTrials":54,"cells":531},{"EARLY_PHASE1":532,"PHASE1":534,"PHASE2":536,"PHASE3":542,"PHASE4":544,"NA":546},{"trials":533,"activeCount":58},[],{"trials":535,"activeCount":58},[],{"trials":537,"activeCount":58},[538],{"nctId":514,"briefTitle":515,"status":136,"phases":539,"primaryCompletion":517,"completion":518,"start":519,"enrollment":520,"conditions":540,"interventions":541},[48],[31,21],[505,523],{"trials":543,"activeCount":58},[],{"trials":545,"activeCount":58},[],{"trials":547,"activeCount":58},[],{"intervention":549,"totalTrials":54,"cells":550},"Riboflavin",{"EARLY_PHASE1":551,"PHASE1":553,"PHASE2":555,"PHASE3":567,"PHASE4":569,"NA":571},{"trials":552,"activeCount":58},[],{"trials":554,"activeCount":58},[],{"trials":556,"activeCount":58},[557],{"nctId":558,"briefTitle":559,"status":166,"phases":560,"primaryCompletion":561,"completion":561,"start":562,"enrollment":563,"conditions":564,"interventions":566},"NCT02514200","Treatment of Keratoconus With Advanced CXL-II",[48],"2019-10","2014-03",50,[565],"Keratoconus",[549],{"trials":568,"activeCount":58},[],{"trials":570,"activeCount":58},[],{"trials":572,"activeCount":58},[],{"intervention":574,"totalTrials":54,"cells":575},"epoprostenol versus normal saline",{"EARLY_PHASE1":576,"PHASE1":578,"PHASE2":591,"PHASE3":593,"PHASE4":595,"NA":597},{"trials":577,"activeCount":58},[],{"trials":579,"activeCount":58},[580],{"nctId":581,"briefTitle":582,"status":136,"phases":583,"primaryCompletion":584,"completion":584,"start":585,"enrollment":586,"conditions":587,"interventions":589},"NCT01363583","Study on the Effect of Prostacyclin Compared to Placebo in Traumatic Brain Injury",[47],"2005-12","2002-01",48,[588],"Traumatic Brain Injury",[574,590],"normal saline",{"trials":592,"activeCount":58},[],{"trials":594,"activeCount":58},[],{"trials":596,"activeCount":58},[],{"trials":598,"activeCount":58},[],{"intervention":590,"totalTrials":54,"cells":600},{"EARLY_PHASE1":601,"PHASE1":603,"PHASE2":609,"PHASE3":611,"PHASE4":613,"NA":615},{"trials":602,"activeCount":58},[],{"trials":604,"activeCount":58},[605],{"nctId":581,"briefTitle":582,"status":136,"phases":606,"primaryCompletion":584,"completion":584,"start":585,"enrollment":586,"conditions":607,"interventions":608},[47],[588],[574,590],{"trials":610,"activeCount":58},[],{"trials":612,"activeCount":58},[],{"trials":614,"activeCount":58},[],{"trials":616,"activeCount":58},[],{"intervention":618,"totalTrials":54,"cells":619},"Metformin",{"EARLY_PHASE1":620,"PHASE1":622,"PHASE2":624,"PHASE3":626,"PHASE4":628,"NA":630},{"trials":621,"activeCount":58},[],{"trials":623,"activeCount":58},[],{"trials":625,"activeCount":58},[],{"trials":627,"activeCount":58},[],{"trials":629,"activeCount":58},[],{"trials":631,"activeCount":58},[632],{"nctId":633,"briefTitle":634,"status":166,"phases":635,"primaryCompletion":636,"completion":637,"start":638,"enrollment":639,"conditions":640,"interventions":642},"NCT03718715","The Interaction Between Metformin and Microbiota - the MEMO Study.",[],"2021-12","2022-03","2019-02-20",600,[641],"Type 2 Diabetes Mellitus",[618],{"intervention":644,"totalTrials":54,"cells":645},"Ropivacaine 5 mg\u002Fml, 35 ml",{"EARLY_PHASE1":646,"PHASE1":648,"PHASE2":650,"PHASE3":652,"PHASE4":654,"NA":656},{"trials":647,"activeCount":58},[],{"trials":649,"activeCount":58},[],{"trials":651,"activeCount":58},[],{"trials":653,"activeCount":58},[],{"trials":655,"activeCount":58},[],{"trials":657,"activeCount":58},[658],{"nctId":659,"briefTitle":660,"status":136,"phases":661,"primaryCompletion":662,"completion":662,"start":663,"enrollment":112,"conditions":664,"interventions":670},"NCT03117894","PECS-2 for Breast Surgery",[51],"2020-10-22","2017-05-23",[665,666,667,668,669],"Breast Neoplasm Female","Regional Anesthesia","Anesthesia","Regional Anesthesia Morbidity","Anesthesia Morbidity",[644,671,672,673,674,675,676,677],"Remifentanil 50 microg\u002Fml","Betamethason 4 mg","Paracetamol 1,5 g","Propofol","Arcoxia, 120 mg","Ondansetron 4 mg","Morphine",{"intervention":671,"totalTrials":54,"cells":679},{"EARLY_PHASE1":680,"PHASE1":682,"PHASE2":684,"PHASE3":686,"PHASE4":688,"NA":690},{"trials":681,"activeCount":58},[],{"trials":683,"activeCount":58},[],{"trials":685,"activeCount":58},[],{"trials":687,"activeCount":58},[],{"trials":689,"activeCount":58},[],{"trials":691,"activeCount":58},[692],{"nctId":659,"briefTitle":660,"status":136,"phases":693,"primaryCompletion":662,"completion":662,"start":663,"enrollment":112,"conditions":694,"interventions":695},[51],[665,666,667,668,669],[644,671,672,673,674,675,676,677],{"intervention":672,"totalTrials":54,"cells":697},{"EARLY_PHASE1":698,"PHASE1":700,"PHASE2":702,"PHASE3":704,"PHASE4":706,"NA":708},{"trials":699,"activeCount":58},[],{"trials":701,"activeCount":58},[],{"trials":703,"activeCount":58},[],{"trials":705,"activeCount":58},[],{"trials":707,"activeCount":58},[],{"trials":709,"activeCount":58},[710],{"nctId":659,"briefTitle":660,"status":136,"phases":711,"primaryCompletion":662,"completion":662,"start":663,"enrollment":112,"conditions":712,"interventions":713},[51],[665,666,667,668,669],[644,671,672,673,674,675,676,677],{"intervention":673,"totalTrials":54,"cells":715},{"EARLY_PHASE1":716,"PHASE1":718,"PHASE2":720,"PHASE3":722,"PHASE4":724,"NA":726},{"trials":717,"activeCount":58},[],{"trials":719,"activeCount":58},[],{"trials":721,"activeCount":58},[],{"trials":723,"activeCount":58},[],{"trials":725,"activeCount":58},[],{"trials":727,"activeCount":58},[728],{"nctId":659,"briefTitle":660,"status":136,"phases":729,"primaryCompletion":662,"completion":662,"start":663,"enrollment":112,"conditions":730,"interventions":731},[51],[665,666,667,668,669],[644,671,672,673,674,675,676,677],{"intervention":674,"totalTrials":54,"cells":733},{"EARLY_PHASE1":734,"PHASE1":736,"PHASE2":738,"PHASE3":740,"PHASE4":742,"NA":744},{"trials":735,"activeCount":58},[],{"trials":737,"activeCount":58},[],{"trials":739,"activeCount":58},[],{"trials":741,"activeCount":58},[],{"trials":743,"activeCount":58},[],{"trials":745,"activeCount":58},[746],{"nctId":659,"briefTitle":660,"status":136,"phases":747,"primaryCompletion":662,"completion":662,"start":663,"enrollment":112,"conditions":748,"interventions":749},[51],[665,666,667,668,669],[644,671,672,673,674,675,676,677],{"intervention":675,"totalTrials":54,"cells":751},{"EARLY_PHASE1":752,"PHASE1":754,"PHASE2":756,"PHASE3":758,"PHASE4":760,"NA":762},{"trials":753,"activeCount":58},[],{"trials":755,"activeCount":58},[],{"trials":757,"activeCount":58},[],{"trials":759,"activeCount":58},[],{"trials":761,"activeCount":58},[],{"trials":763,"activeCount":58},[764],{"nctId":659,"briefTitle":660,"status":136,"phases":765,"primaryCompletion":662,"completion":662,"start":663,"enrollment":112,"conditions":766,"interventions":767},[51],[665,666,667,668,669],[644,671,672,673,674,675,676,677],{"intervention":676,"totalTrials":54,"cells":769},{"EARLY_PHASE1":770,"PHASE1":772,"PHASE2":774,"PHASE3":776,"PHASE4":778,"NA":780},{"trials":771,"activeCount":58},[],{"trials":773,"activeCount":58},[],{"trials":775,"activeCount":58},[],{"trials":777,"activeCount":58},[],{"trials":779,"activeCount":58},[],{"trials":781,"activeCount":58},[782],{"nctId":659,"briefTitle":660,"status":136,"phases":783,"primaryCompletion":662,"completion":662,"start":663,"enrollment":112,"conditions":784,"interventions":785},[51],[665,666,667,668,669],[644,671,672,673,674,675,676,677],{"intervention":677,"totalTrials":54,"cells":787},{"EARLY_PHASE1":788,"PHASE1":790,"PHASE2":792,"PHASE3":794,"PHASE4":796,"NA":798},{"trials":789,"activeCount":58},[],{"trials":791,"activeCount":58},[],{"trials":793,"activeCount":58},[],{"trials":795,"activeCount":58},[],{"trials":797,"activeCount":58},[],{"trials":799,"activeCount":58},[800],{"nctId":659,"briefTitle":660,"status":136,"phases":801,"primaryCompletion":662,"completion":662,"start":663,"enrollment":112,"conditions":802,"interventions":803},[51],[665,666,667,668,669],[644,671,672,673,674,675,676,677],{"intervention":805,"totalTrials":54,"cells":806},"Diflunisal",{"EARLY_PHASE1":807,"PHASE1":809,"PHASE2":811,"PHASE3":813,"PHASE4":815,"NA":817},{"trials":808,"activeCount":58},[],{"trials":810,"activeCount":58},[],{"trials":812,"activeCount":58},[],{"trials":814,"activeCount":58},[],{"trials":816,"activeCount":58},[],{"trials":818,"activeCount":58},[819],{"nctId":820,"briefTitle":821,"status":136,"phases":822,"primaryCompletion":428,"completion":428,"start":823,"enrollment":429,"conditions":824,"interventions":826},"NCT01432587","The Effect of Diflunisal on Familial Transthyretin Amyloidosis",[],"2011-08",[825],"Amyloidosis",[805],{"intervention":828,"totalTrials":54,"cells":829},"HighOsmo",{"EARLY_PHASE1":830,"PHASE1":832,"PHASE2":834,"PHASE3":836,"PHASE4":838,"NA":840},{"trials":831,"activeCount":58},[],{"trials":833,"activeCount":58},[],{"trials":835,"activeCount":58},[],{"trials":837,"activeCount":58},[],{"trials":839,"activeCount":58},[],{"trials":841,"activeCount":58},[842],{"nctId":843,"briefTitle":844,"status":136,"phases":845,"primaryCompletion":846,"completion":846,"start":847,"enrollment":112,"conditions":848,"interventions":852},"NCT05914896","Hyperosmolality and Acute Kidney Injury After Cardiac Surgery",[51],"2020-06-24","2019-04-24",[849,850,851],"Acute Kidney Injury","Osmolality Disturbance","Cardiopulmonary Bypass",[828],{"intervention":854,"totalTrials":54,"cells":855},"Vaccination",{"EARLY_PHASE1":856,"PHASE1":858,"PHASE2":860,"PHASE3":862,"PHASE4":864,"NA":866},{"trials":857,"activeCount":58},[],{"trials":859,"activeCount":58},[],{"trials":861,"activeCount":58},[],{"trials":863,"activeCount":58},[],{"trials":865,"activeCount":58},[],{"trials":867,"activeCount":58},[868],{"nctId":869,"briefTitle":870,"status":166,"phases":871,"primaryCompletion":872,"completion":873,"start":874,"enrollment":875,"conditions":876,"interventions":879},"NCT04920357","Immune Response to Vaccination Against Covid-19, a Follow up Study",[],"2022-03-31","2024-12-31","2021-03-31",3000,[877,878],"Vaccination; Infection","Covid19",[854],{"intervention":881,"totalTrials":54,"cells":882},"Latanoprost",{"EARLY_PHASE1":883,"PHASE1":885,"PHASE2":887,"PHASE3":889,"PHASE4":891,"NA":893},{"trials":884,"activeCount":58},[],{"trials":886,"activeCount":58},[],{"trials":888,"activeCount":58},[],{"trials":890,"activeCount":58},[],{"trials":892,"activeCount":58},[],{"trials":894,"activeCount":58},[895],{"nctId":896,"briefTitle":897,"status":166,"phases":898,"primaryCompletion":899,"completion":899,"start":900,"enrollment":901,"conditions":902,"interventions":904},"NCT02656979","Blood Flow of Ophthalmic Artery and Glaucoma",[51],"2019-09","2013-12",125,[903],"Glaucoma",[881]]